UCL School of Life and Medical Sciences



Drug repurposing is the process of discovering new therapeutic uses for existing drugs.
Drug repurposing can encompass any one of the following activities: 

  • Repositioning drug candidates that are currently in clinical development to new disease indications
  • Targeting drugs that have been abandoned or failed to demonstrate efficacy for a particular indication during phase II or III trials to new disease indications 
  • Targeting marketed or off-patent drugs to new disease indications
  • Reformulation of drugs including novel delivery systems 
  • Novel combination therapies

The Repurposing Therapeutic Innovation Network aims to shape the pathway to accelerate the translational process for UCL repurposing projects. To achieve this we need to: 

  • Scope ongoing repurposing activities
  • Establish core group

If you are involved/interested in repurposing and want to be part of shaping the Repurposing TIN please contact us